Nykode Therapeutics – Grant of Share Options

10 Oct 2025 17:44 CEST

Oslo, Norway, October 10, 2025 – Nykode Therapeutics ASA (OSE: NYKD), a
clinical-stage biopharmaceutical company dedicated to the discovery and
development of novel immunotherapies, today announced that 1,200,000 share
options have been granted to an employee and primary insider under the company’s
share option scheme. The share options will have a strike price of NOK 7.00 per
share, vest equally over a four-year vesting period and expire in 2030.

Please see further details in attached document.

More information:
Access the news on Oslo Bors NewsWeb site

657010_Attachment Options 251010.pdf